CMS Q2 2026 HCPCS Update: 15 New Drug Codes for Oct. 1
CMS’s Q2 2026 HCPCS decisions add 15 new drug and biosimilar codes for October 1 and deny two closely watched revision requests.
·
CMS’s Q2 2026 HCPCS decisions add 15 new drug and biosimilar codes for October 1 and deny two closely watched revision requests.
·